Patents by Inventor Surbhi Goel

Surbhi Goel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Genetically Modifying CIITA in a Cell
    Publication number: 20240139323
    Abstract: Compositions and methods for reducing MHC class II protein expression in a cell comprising genetically modifying CIITA for use e.g., in adoptive cell transfer therapies.
    Type: Application
    Filed: June 22, 2023
    Publication date: May 2, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: William Frederick Harrington, Surbhi Goel
  • Compositions and Methods for Reducing HLA-A in a Cell
    Publication number: 20240024478
    Abstract: Compositions and methods for reducing HLA-A protein expression in a cell comprising genetically modifying HLA-A for use e.g., in adoptive cell transfer therapies.
    Type: Application
    Filed: June 22, 2023
    Publication date: January 25, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Surbhi Goel, Yong Zhang, Reynald Michael Lescarbeau, Bradley Andrew Murray, Srijani Sridhar
  • Compositions and Methods for Reducing MHC Class II in a Cell
    Publication number: 20240016934
    Abstract: Compositions and methods for reducing MHC class II protein expression in a cell comprising genetically modifying CIITA for use e.g., in adoptive cell transfer therapies.
    Type: Application
    Filed: June 9, 2023
    Publication date: January 18, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Srijani Sridhar, Yong Zhang, William Frederick Harrington, Surbhi Goel
  • Compositions and Methods for Immunotherapy
    Publication number: 20210340530
    Abstract: Compositions and methods for editing, e.g., altering a DNA sequence, within the TRBC1, TRBC2 and/or TRAC genes are provided. Compositions and methods for immunotherapy are provided, for example.
    Type: Application
    Filed: April 15, 2021
    Publication date: November 4, 2021
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Amy Melissa Becker, Surbhi Goel, Sarah Beth Hesse, Troy Aaron Luster, Birgit Schultes, Stephanie A. Yazinski, Pooja Vinay